| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 03/03/2011 | US20110052612 Spiropiperidine compound and medicinal use thereof |
| 03/03/2011 | US20110052562 Benzimidazoles and analogs as rho kinase inhibitors |
| 03/03/2011 | US20110052528 Neuroprotective macrocyclic compounds and methods for their use |
| 03/03/2011 | US20110052527 Imidazopyridinyl thiazolyl histone deacetylase inhibitors |
| 03/03/2011 | US20110049485 Organic light-emitting device |
| 03/03/2011 | US20110049479 BENZO[a]FLUORANTHENE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME |
| 03/03/2011 | CA2772316A1 1h-pyrazolo [3,4-b] pyridine compounds for inhibiting raf kinase |
| 03/03/2011 | CA2772169A1 (thio)morpholine derivatives as s1p modulators |
| 03/03/2011 | CA2771939A1 Methylpyrrolopyridinecarboxamides |
| 03/03/2011 | CA2771833A1 Fused heterocyclic ring derivative and use thereof |
| 03/03/2011 | CA2769151A1 5,6-bicyclic heteroaryl-containing urea compounds as kinase inhibitors |
| 03/02/2011 | EP2289892A1 Maleimide derivatives, pharmaceutical compositions amd methods for treatment of cancer |
| 03/02/2011 | EP2289882A1 3-oxopiperazinium derivatives as agonists of nerve growth factor and their use as medicaments |
| 03/02/2011 | EP2289877A1 Organic light emitting device containing polycyclic heteroaryl compounds |
| 03/02/2011 | EP2288609A2 Indolyl-pyridazinyl-diazabicyclononane derivatives in labelled and unlabelled form and their use in diagnostic methods |
| 03/02/2011 | EP2288608A1 Novel oxadiazolyl-diazabicyclononane derivatives and their medical use |
| 03/02/2011 | EP2288605A1 Annelated pyrrolidin sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals |
| 03/02/2011 | EP2288604A1 Annelated n-heterocyclic sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals |
| 03/02/2011 | EP2288601A1 Bicyclylaryl-aryl-amine compounds and their use |
| 03/02/2011 | EP2288596A2 Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use |
| 03/02/2011 | EP2288351A2 Novel pyrrolidone derivatives for use as metap-2 inhibitors |
| 03/02/2011 | EP2092794B1 Phenanthroline compounds and electroluminescent devices using the same |
| 03/02/2011 | CN1918158B Compounds and compositions as protein kinase inhibitors |
| 03/02/2011 | CN101983198A Pyrido [4, 3-d] pyrimidinone derivatives as kinase inhibitors |
| 03/02/2011 | CN101983190A Fluorine derivatives for organic electroluminescence devices |
| 03/02/2011 | CN101983059A New 2,3,4,5-terahydro-1h-pyrido[ 4,3-b] indole compounds and methods of use thereof |
| 03/02/2011 | CN101193869B Glucocortioid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 03/01/2011 | US7897771 Fused heterocyclic compounds |
| 03/01/2011 | US7897767 Oxime substituted imidazoquinolines |
| 03/01/2011 | US7897765 Therapeutic compounds and uses thereof |
| 03/01/2011 | US7897632 Multi-cyclic cinnamide derivatives |
| 03/01/2011 | US7897618 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 03/01/2011 | US7897616 Imidazopyridin-2-one derivatives as inhibitors of lipases and phospholipases |
| 03/01/2011 | US7897610 Use of benzo[c]quinolizinium derivatives for the treatment of diseases that are linked to smooth muscle cell constriction |
| 03/01/2011 | US7897607 Cyclic compounds |
| 03/01/2011 | US7897597 Aryloxy and arylalkyleneoxy substituted imidazoquinolines |
| 02/24/2011 | WO2011022678A1 Fluorinated aromatic materials and their use in optoelectronics |
| 02/24/2011 | WO2011022213A1 Amino tetrahydro-pyridopyrimidine pde10 inhibitors |
| 02/24/2011 | WO2011021726A2 Nitrogen-containing compound and pharmaceutical composition |
| 02/24/2011 | WO2011021689A1 Cyclic azine derivatives, processes for producing these, and organic electroluminescent element containing these as component |
| 02/24/2011 | WO2011021678A1 Fused heterocyclic compound |
| 02/24/2011 | WO2011021545A1 Heterocyclic compound and organic light-emitting device using the same |
| 02/24/2011 | WO2011020861A1 Heterocyclic oxime compounds |
| 02/24/2011 | WO2011000945A3 Aminoalkamides for use in the treatment of inflammatory, degenerative or demyelinating diseases of the cns |
| 02/24/2011 | WO2010149944A8 Indolyl-substituted pyrazino-quinolines and their use for the treatment of cancer |
| 02/24/2011 | WO2010114267A3 Organic electronic device, compounds for same, and terminal |
| 02/24/2011 | WO2009149139A8 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 02/24/2011 | US20110046378 Novel Imaging Agents for Detecting Neurological Dysfunction |
| 02/24/2011 | US20110046377 Tetrahydropyridoethers for treatment of amd |
| 02/24/2011 | US20110046368 Ligands of 5-ht6 receptors, a pharmaceutical composition, method for the production and use thereof |
| 02/24/2011 | US20110046171 Arylsulfonyl pyrazoline carboxamidine derivatives as 5-ht6 antagonists |
| 02/24/2011 | US20110046169 Fused heterocyclic derivatives and use thereof |
| 02/24/2011 | US20110046162 Fused cyanopyridines and the use thereof |
| 02/24/2011 | US20110046149 2-amino-3-sulphonyl-tetrahydro-pyrazolo[1,5-a]pyrido-pyrimidine antagonists of serotonin 5-ht6 receptors, methods for the production and use thereof |
| 02/24/2011 | US20110046145 Quinolizidinone M1 Receptor Positive Allosteric Modulators |
| 02/24/2011 | US20110046137 Pyrazole Derivatives as P2X7 Modulators |
| 02/24/2011 | US20110046132 Benzoimidazoles as prolyl hydroxylase inhibitors |
| 02/24/2011 | US20110046130 Tetrahydronaphthyridines and aza derivatives thereof as histamine h3 receptor antagonists |
| 02/24/2011 | US20110046109 2,4,8-trisubstituted-8h-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy |
| 02/24/2011 | US20110046102 Azabicyclic compounds, preparation thereof and use of same as drugs, especially beta-lactamase inhibitors |
| 02/24/2011 | US20110046097 Substituted indolin-2-one derivatives and their use as p38 mitogen-activated kinase inhibitors |
| 02/24/2011 | US20110045503 The Use of Novel Coumarins as Glutathione and Thiol Labels |
| 02/24/2011 | US20110044899 Labelled analogues of halobenzamides as multimodal radiopharmaceuticals and their precursors |
| 02/24/2011 | US20110042651 Liquid crystalline rylene tetracarboxylic acid derivatives and use thereof |
| 02/24/2011 | CA2771579A1 Nitrogen-containing compound and pharmaceutical composition |
| 02/24/2011 | CA2771532A1 Heterocyclic compounds and uses thereof |
| 02/24/2011 | CA2771432A1 Heterocyclic oxime compounds |
| 02/23/2011 | EP2287167A1 Polycyclic agents for the treatment of respiratory syncytial virus infections |
| 02/23/2011 | EP2287166A2 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 02/23/2011 | EP2287165A2 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 02/23/2011 | EP2287163A1 2-amino-3-sulphonyl-tetrahydro-pyrazolo[1,5-a]pyrido-pyrimidine antagonists of serotonin 5-ht6 receptors, methods for the production and use thereof |
| 02/23/2011 | EP2286811A1 Chemokine receptor antagonists and methods of use thereof |
| 02/23/2011 | EP2286795A1 Method of producing a cationic liposomal preparation comprising a lipophilic compound |
| 02/23/2011 | EP2285808A1 Spiro-indole derivatives for the treatment of parasitic diseases |
| 02/23/2011 | EP2285807A1 Heterocyclic antiviral compounds |
| 02/23/2011 | EP2285806A1 Threefold and fourfold substituted pentarylene tetracarboxylic acid diimides |
| 02/23/2011 | EP2285805A1 Aryl-quinolyl compounds and their use |
| 02/23/2011 | EP2285804A2 A process for the preparation of paliperidone intermediates |
| 02/23/2011 | EP2285786A1 Quinoxalinedione derivatives |
| 02/23/2011 | EP2285375A2 Spiroazaindoles |
| 02/23/2011 | EP2027123B1 Compounds and compositions as protein kinase inhibitors |
| 02/23/2011 | EP1919910B1 Azabenzimidazole derivatives, their manufacture and use as anti-cancer agents |
| 02/23/2011 | EP1812388B1 Sulfonamide peri-substituted bicyclics for occlusive artery disease |
| 02/23/2011 | EP1720873B1 Diaza-spiropiperidine derivatives |
| 02/23/2011 | EP1697360B1 Novel crystalline forms of 2, 3 dimethyl-8- (2, 6-dimethylbenzylamino) -n-hydroxyethyl-imidazo 1, 2-a pyridine-6-carboxamide mesylate salt. |
| 02/23/2011 | EP1031571B1 Sulfamoyl compounds and agricultural or horticultural bactericide |
| 02/23/2011 | CN1751042B Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors |
| 02/23/2011 | CN101981025A Diarylmethylamide derivative having antagonistic activity on melanin-concentrating hormone receptor |
| 02/23/2011 | CN101980707A Novel substituted imidazoquinolines |
| 02/23/2011 | CN101978962A Medicinal composition for colon cancer and method for preparing effective monomers thereof |
| 02/23/2011 | CN101142214B Ocaperidone salts and pharmaceutical compositions containing the same |
| 02/22/2011 | US7893280 2,4-disubstituted thiazolyl derivatives |
| 02/22/2011 | US7893265 Methods for preparing arene-BIS (dicarboximide)-based semiconducting materials and related intermediates for preparing same |
| 02/22/2011 | US7893259 Pyrido-pyrimidine derivatives, preparation thereof, and therapeutic use thereof |
| 02/22/2011 | US7893090 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 02/22/2011 | US7893086 Sirtuin modulating compounds |
| 02/22/2011 | US7893084 Viral polymerase inhibitors |
| 02/22/2011 | US7893082 Substituted tetrahydroquinolines |
| 02/22/2011 | US7893075 Compounds modulating c-fms and/or c-kit activity and uses therefor |
| 02/22/2011 | US7893071 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic |